Oxcarbazepine
- Product NDC
- 21695-862
- 11-digit product format
- 216950862
- Labeler code
- 21695
- Product ID
- 21695-862_e8a485af-a78b-49a0-9bf4-75e1cd5bb740
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Oxcarbazepine
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Labeler
- Rebel Distributors Corp
- Application
- ANDA077802
- Marketing category
- ANDA
- Marketing start
- 2007-10-09
- Marketing end
- 0000-00-00
- Substance
- OXCARBAZEPINE
- Active strength
- 150 mg/1
- Pharmacologic classes
- Anti-epileptic Agent [EPC],Decreased Central Nervous System Disorganized Electrical Activity [PE]
- NDC exclude flag
- E
- Listing certified through
- 2017-12-31
- Current FDA listing
- Historical FDA.report record
NDC auxiliary status#
Explicit status records from FDA unfinished, excluded, and compounder auxiliary files. Absence of a row is not itself a regulatory status. Browse every current auxiliary row, including rows without a usable NDC. · Browse every captured source and parsed snapshot.
| Dataset | Scope | Product NDC | Package NDC | Code | Status | Reporting period | Source date |
|---|---|---|---|---|---|---|---|
| excluded product | product | 21695-862 | I | Inactivated by FDA | 2026-07-31 | ||
| excluded package | package | 21695-862 | 21695-862-30 | I | Inactivated by FDA | 2026-07-31 | |
| excluded package | package | 21695-862 | 21695-862-60 | I | Inactivated by FDA | 2026-07-31 |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A077802-001 | OXCARBAZEPINE | OXCARBAZEPINE | 150MG | TABLET / ORAL | AB | 2007-10-09 | |
| A077802-002 | OXCARBAZEPINE | OXCARBAZEPINE | 300MG | TABLET / ORAL | AB | 2007-10-09 | |
| A077802-003 | OXCARBAZEPINE | OXCARBAZEPINE | 600MG | TABLET / ORAL | AB | 2007-10-09 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A077802-001 | AB |
| A077802-002 | AB |
| A077802-003 | AB |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | A077802-001 | OXCARBAZEPINE | 150MG | TABLET / ORAL | AB | 2007-10-09 | a50c72e98297… | |
| 2026-08-01 22:54:32 | 2026-06 | A077802-002 | OXCARBAZEPINE | 300MG | TABLET / ORAL | AB | 2007-10-09 | a50c72e98297… | |
| 2026-08-01 22:54:32 | 2026-06 | A077802-003 | OXCARBAZEPINE | 600MG | TABLET / ORAL | AB | 2007-10-09 | a50c72e98297… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | A077802-001 | AB | 1 | a50c72e98297… |
| 2026-08-01 22:54:32 | 2026-06 | A077802-002 | AB | 1 | a50c72e98297… |
| 2026-08-01 22:54:32 | 2026-06 | A077802-003 | AB | 1 | a50c72e98297… |
openFDA label cross-check#
Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Oxcarbazepine | OXCARBAZEPINE | Coupler LLC | 51008af2-39ac-546c-e063-6294a90a758f | 2026-05-04 | Warnings, Adverse reactions | 077802 ANDA077802 |
| Oxcarbazepine | OXCARBAZEPINE | Coupler LLC | 50873ef7-3deb-7386-e063-6394a90a9c19 | 2026-04-28 | Warnings, Adverse reactions | 077802 ANDA077802 |
| Oxcarbazepine | OXCARBAZEPINE | REMEDYREPACK INC. | a90cd1f1-5258-4b0e-92fd-c4cebe47772b | 2026-04-06 | Warnings, Adverse reactions | 077802 ANDA077802 |
| Oxcarbazepine | OXCARBAZEPINE | REMEDYREPACK INC. | a2032bcc-2da5-45e5-aa3f-ddbf50909df8 | 2026-02-17 | Warnings, Adverse reactions | 077802 ANDA077802 |
| Oxcarbazepine | OXCARBAZEPINE | Glenmark Pharmaceuticals Inc., USA | 1c713b59-a628-42e6-b166-ae71c3913284 | 2025-12-03 | Warnings, Adverse reactions | 077802 ANDA077802 |
| Oxcarbazepine | OXCARBAZEPINE | Direct_rx | 21b0cc84-b64a-75de-e063-6294a90a9dd0 | 2024-09-09 | Warnings, Adverse reactions | 077802 ANDA077802 |
| Oxcarbazepine | OXCARBAZEPINE | Proficient Rx LP | 95867dcd-fd0e-4570-987b-d35939f7d7d1 | 2022-11-01 | Warnings, Adverse reactions | 077802 ANDA077802 |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| ca2a6da1-5711-44d0-9e79-c84d4265f98b | Product name | 3 | 20250724 |
| 536d5b6b-66f1-478b-2670-88fd15947e3b | Product name | 7 | 20250218 |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 21695-862-30 | 2019-09-24 | C162847 | 48780-1 | 934fe258-4905-48b1-e053-8cdaa90a720a | Oxcarbazepine Tablets |
| 21695-862-60 | 2019-09-24 | C162847 | 48780-1 | 934fe258-4905-48b1-e053-8cdaa90a720a | Oxcarbazepine Tablets |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 21695-862-30 | Oxcarbazepine | 30 in 1 BOTTLE | TABLET, FILM COATED | 30 | 1 | |
| 21695-862-60 | Oxcarbazepine | 60 in 1 BOTTLE | TABLET, FILM COATED | 60 | 1 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 21695-862-30 | EA - Each | 21695-862 | 036c597f-5a8e-4f4a-aa4b-059ac2c86c65 | 1 | 2012-07-24 |
| 21695-862-60 | EA - Each | 21695-862 | 42fd2351-5539-4fb7-87ca-6889bba1d82d | 1 | 2012-07-24 |
DailyMed Socrata Ingredients#
DailyMed Dashboard NDC Coverage#
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 312136 | OXcarbazepine 150 MG Oral Tablet | PSN | e8a485af-a78b-49a0-9bf4-75e1cd5bb740 | 1 |
| 312137 | OXcarbazepine 300 MG Oral Tablet | PSN | e8a485af-a78b-49a0-9bf4-75e1cd5bb740 | 1 |
| 312138 | OXcarbazepine 600 MG Oral Tablet | PSN | e8a485af-a78b-49a0-9bf4-75e1cd5bb740 | 1 |
| 312136 | oxcarbazepine 150 MG Oral Tablet | SCD | e8a485af-a78b-49a0-9bf4-75e1cd5bb740 | 1 |
| 312137 | oxcarbazepine 300 MG Oral Tablet | SCD | e8a485af-a78b-49a0-9bf4-75e1cd5bb740 | 1 |
| 312138 | oxcarbazepine 600 MG Oral Tablet | SCD | e8a485af-a78b-49a0-9bf4-75e1cd5bb740 | 1 |
Packages#
| Package NDC | 11-digit format | Description | Status |
|---|---|---|---|
| 21695-862-30 | 21695086230 | 30 in 1 BOTTLE | Historical |
| 21695-862-60 | 21695086260 | 60 in 1 BOTTLE | Historical |